CompletedPhase 3NCT02267096

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

In 2011, the National Lung Screening Trial (NLST) reported that lung cancer mortality was reduced by 20% with spiral computed tomography (CT) compared to chest X-ray. It is estimated that 8 million people in the US are at high risk for lung cancer and that lung screening could prevent 12,000 deaths annually. Cost effectiveness models suggest that concurrent smoking cessation programs will be essential in order to realize the full benefit of screening. However, there are no clinical guidelines or evidence-based cessation protocols with demonstrated effectiveness in this setting. The investigators are addressing this gap by rigorously testing whether two scalable and pragmatic interventions can significantly boost intention to quit and cessation rates.

Checked against the public recordLast updated Oct 19, 2016 · Source: ClinicalTrials.gov

StatusCompleted
PhasePhase 3
U.S. locations3
SponsorGeorgetown University
01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 3
Sponsor
Georgetown University
Interventions being studied
Behavioral: Telephone Counseling; Behavioral: Minimal Treatment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: 1. 55-80 years old 2. current smoker 3. \> 30-pack years 4. English-speaking 5. ability to provide meaningful consent 6. enrolled to undergo lung cancer screening. - Exclusion Criteria: 1. history of lung cancer 2. current treatment for other cancer -

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Georgetown University Medical CenterWashington D.C., District of Columbia
  • Lahey Hospital and Medical CenterBurlington, Massachusetts
  • Hackensack University Medical CenterHackensack, New Jersey

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 19, 2016. Always confirm current availability with the study team.

View original record ↗